Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry

Molecular & Cellular Proteomics(2023)10.1016/j.mcpro.2023.100563Source: DataRank Database

Sensitive, High-Throughput HLA-I and HLA-II Immunopeptidomics Using Parallel Accumulation-Serial Fragmentation Mass Spectrometry is a research paper published in Molecular & Cellular Proteomics (2023). On theSindex it has a DataRank of 0. It has been cited 50 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access50 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 4.56)OA: goldTopics (32)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Claudia Ctortecka ORCID,Alvaro Sebastian Vaca Jácome ORCID,Susan Klaeger ORCID,Eva K. Verzani ORCID,Gabrielle M. Hernandez ORCID

Live enrichment

PubMed:37142057 OpenAlex:https://openalex.org/W4367692825

Swiss National Science Foundation

Grant: CRSII5_186405

National Institutes of Health

Grant: P01CA206978

National Cancer Institute

Grant: U01CA271402

National Cancer Institute

Grant: U24CA270823

FWCI

4.56

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.mcponline.org/article/S1535947623000737/pdf

publisherhttp://www.mcponline.org/article/S1535947623000737/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1535947623000737?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1535947623000737?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.mcpro.2023.100563

Fields of Study

vaccines and immunoinformatics approachesPeptidase Inhibition and AnalysisImmunotherapy and Immune ResponsesMaleHumansHistocompatibility Antigens Class IMass SpectrometryNeoplasmsPeptidesCell Line

MeSH Terms

Cell LineHumansMaleNeoplasmsPeptidesMass SpectrometryHistocompatibility Antigens Class I

Keywords

Fragmentation (computing)Human leukocyte antigenMass spectrometryChemistryThroughputComputational biologyComputer scienceChromatographyBiologyGeneticsAntigenHLA-I and II immunopeptidomicshigh-throughput acquisitionsensitive single-shot MS analysistrapped ion mobility

Sustainable Development Goals

SDG 0: Good health and well-being